It is prospective that new drug development with aldose reductase as a potential target can achieve significant progress. 预计以醛糖还原酶为靶点的新药研究和开发将取得重要进展。
Using epalrestat as a control, the aldose reductase inhibitory activities of the compounds obtained were evaluated on rat lens aldose reductase in vitro. 以依帕司他为阳性对照药,采用大鼠晶状体醛糖还原酶对目标化合物醛糖还原酶抑制活性进行初步评价。